Is cigarette smoking a risk factor for systemic lupus erythematosus? Comment on the article by Costenbader et al - Reply

被引：0

作者：

Costenbader, KH ^{[1
]}

Peerzada, J

Lockman, S

Karlson, EW

Kim, DJ

Nobles-Knight, D

Petri, M

机构：

[1] Harvard Univ, Sch Med, Cambridge, MA 02138 USA

[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

[3] Pfizer Inc, Chicago, IL USA

[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

来源：

ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 04期

关键词：

D O I：

10.1002/art.21094

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1341 / 1341

页数：1

共 50 条

[41] Pain and Psychological Distress in Patients With Systemic Lupus Erythematosus: Comment on the Article by Somers et al
Navarrete-Navarrete, Nuria
Jimenez-Alonso, Juan
Mario Sabio, Jose
Isabel Peralta-Ramirez, Maria
ARTHRITIS CARE & RESEARCH, 2013, 65 (07) : 1204 - 1204
[42] Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: comment on the article by Efthimiou et al
Zhang, Hong-Liang
Qin, Gui-Xiang
Fan, Zhen-Yi
Wu, Jiang
ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 309 - 309
[43] Refining research on systemic lupus erythematosus with key considerations: comment on the article by Xing et al
Zhou, Qing
ARTHRITIS & RHEUMATOLOGY, 2025, 77 (01) : 117 - 117
[44] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al
Major, Gabor A. C.
ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1157 - 1158
[45] Galectin 9: Friend or Foe of Systemic Lupus Erythematosus? Comment on the Article by Zeggar et al
Xu, Wang-Dong
Su, Lin-Chong
Huang, An-Fang
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (05) : 832 - 832
[46] Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al
Sulu, Bercemhan
Tascilar, Koray
ARTHRITIS & RHEUMATOLOGY, 2025,
[47] Cigarette smoking and systemic lupus erythematosus: A smoking gun?
Costenbader, KH
Karlson, EW
AUTOIMMUNITY, 2005, 38 (07) : 541 - 547
[48] Skin-lightening creams are a possible exposure risk for systemic lupus erythematosus: comment on the article by Finckh et al
Pollard, K. Michael
ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1721 - 1721
[49] Pertinence of cardiovascular disease risk awareness in adolescent patients with systemic lupus erythematosus: comment on the article by Scalzi et al
Bidwell, C.
Bolt, I.
McDonagh, J. E.
ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3971 - 3972
[50] An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al Reply
Jorge, April M.
Materne, Emma
Zhou, Baijun
Costenbader, Karen
Zhang, Yuqing
Choi, Hyon K.
ARTHRITIS & RHEUMATOLOGY, 2024, 76 (02) : 316 - 317

← 1 2 3 4 5 →